FDA approves AZ's Epanova for severe hypertriglyceridemia

FDA approved an NDA from AstraZeneca plc (LSE:AZN; NYSE:AZN) for Epanova as an adjunct to diet and exercise to treat severe hypertriglyceridemia, defined as triglyceride levels greater than or equal t...